CClinicalTrials.gg
CompletedNCT00884871Updated Nov 11, 2009

Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders

An observational study in Pelvic Floor Disorders, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to female participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-11-11.

Sponsored by University of California, San Diego · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
21 Years and older
Sex
Female
01

Study summary

The specific aim of this study is to evaluate the effect of surgically-induced weight reduction, as achieved by laparoscopic gastric banding or sleeve gastrectomy, on pelvic floor disorders such as stress urinary incontinence, overactive bladder, anal incontinence, and pelvic organ prolapse in severely, morbidly and super-obese women using a prospective, observational study design.

02

Conditions studied

  • Pelvic Floor Disorders

Keywords

  • pelvic floor disorders
  • weight loss
03

In context

Pelvic Floor Disorders

197 studies on the registry are indexed under Pelvic Floor Disorders; 45 are open to participants now.

This study's planned enrollment of 100 is below the median of 140 across 58 observational studies indexed under Pelvic Floor Disorders.

Browse Pelvic Floor Disorders studies →

Lead sponsor

University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.

Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

100 obese women who have met surgical eligibility for laparoscopic adjustable gastric banding at the Center for the Treatment of Obesity at UCSD

Inclusion criteria

  • surgical eligibility met by Center for the Treatment Obesity criteria
  • morbid obesity (BMI > 40 kg/m2) or severe obesity (BMI > 33 kg/m2) in presence of NIH co-morbidities
  • willing to participate in study, including completion of self-reported questionnaires

Exclusion criteria

Exclusion Criteria:

  • pregnancy or planned pregnancy
  • recent pregnancy or pelvic surgery
  • age \< 21 years
  • known neurologic disease or pelvic pathology
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)

Groups and cohorts

  • Laparoscopic adjustable gastric banding

    100 obese women undergoing laparoscopic adjustable gastric banding

    Procedure: LapBand

Interventions

  • ProcedureLapBand

    Prospective observation study of 100 obese women undergoing laparoscopic gastric banding to determine impact of weight loss on pelvic floor disorders

06

What researchers measure

Primary outcomes

  1. Prevalence of pelvic floor disorders ascertained by Epidemiology of Prolapse and Incontinence Questionnaire

    Time frame: 12 months

Secondary outcomes

  1. Weekly incontinence episodes and pad use ascertained by incontinence diary

    Time frame: 12 months

  2. Quality of life impact ascertained by validated measures (PFIQ, PFDI, FISI, and PGI-I)

    Time frame: 12 months

  3. Sexual function ascertained by validated measure (PISQ)

    Time frame: 12 months

07

Study locations

1 site
  • University of California San Diego Medical Center
    La Jolla, California 92037, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 11, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00884871
Lead sponsor
University of California, San Diego
First posted
Apr 21, 2009
Start date
Sep 2007
Primary completion
Nov 2009
Completion
Nov 2009
Last update
Nov 11, 2009

Study contacts

Emily L Whitcomb, M.D.
principal investigator · University of California, San Diego

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion